RAC 1.40% $1.41 race oncology ltd

Cardioprotection thread, page-473

  1. 427 Posts.
    lightbulb Created with Sketch. 206
    One problem I can see with your table JDP, the 10% value appears to be for only one cycle of CPACS. Thinking that $1.1b should be multiplied by four, the optimist amongst us might even go for a 5x or 6x multiplier due to ability to use more anthracyclene if CP allows more max dosage.

    Is that right, or have I missed something?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.